Relapse Prevention
Relapse Prevention - Related Videos
08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
0 Views •
2025
The protocol aims to describe a mouse model for generating relapses of acute lymphoblastic leukemia, based on the dynamics of the response to induction chemotherapy.
10:46
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
0 Views •
Cited by 2 •
2015
Combining plot analysis with trigonometric regression is a robust method for exploring complex, cyclical phenomena such as relapse onset timing in multiple sclerosis (MS). This method enabled unbiased characterisation of seasonal trends in relapse onset permitting novel inferences around the influence of seasonal variation, ultraviolet radiation (UVR) and latitude.
26:48
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
0 Views •
Cited by 27 •
2007
This video demonstrates the induction and clinical scoring of an animal model of multiple sclerosis: chronic-relapsing experimental autoimmune encephalomyelitis in DA rats. The disease, induced by immunizing rats with an emulsion containing whole rat spinal cord and complete Freund's adjuvant, presents clinical signs resembling the human disease.
04:46
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
0 Views •
Cited by 4 •
2023
The present protocol establishes a glioblastoma (GBM) relapse post-resection model using microscopy to investigate the therapeutic effect of an injectable, bioresponsive hydrogel in vivo.
02:59
Cancer Prevention
0 Views •
2021
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer. Some...
FAQs
Trigger identification helps clinicians and patients recognize circumstances associated with increased risk of substance use. This process also highlights early warning signs, allowing coping strategies to be strengthened before a return to use occurs. In practice, recognizing these patterns supports individualized planning and ongoing monitoring throughout recovery.
Pharmacological treatments can address several factors that contribute to recurrence, including cravings, withdrawal symptoms, and the rewarding effects of drugs. By targeting these factors, medication may make recovery easier to sustain. Clinicians can incorporate these treatments into a broader plan that also includes behavioral interventions and monitoring.
These medication categories provide different pharmacological approaches for supporting recovery from substance use disorders. Opioid agonists, antagonists, and partial agonists may be considered when treatment is being tailored to a patient’s needs. Their use is most relevant within a monitored plan that also addresses behavioral and clinical factors.
A plan commonly begins by identifying triggers and early warning signs, then strengthening coping strategies for managing them. Clinicians may also consider pharmacological treatment to address cravings, withdrawal symptoms, or drug-related rewards. Behavioral interventions and ongoing monitoring complete the process by supporting adjustment as recovery progresses.
Relapse prevention is relevant after formal treatment and during later periods of recovery, when the risk of returning to substance use remains important to address. Clinicians can use continued monitoring to recognize warning signs, reassess needs, and maintain appropriate behavioral or pharmacological support over time.
Pharmacology gives clinicians medication-based options that can be matched with the needs of people with substance use disorders. Depending on the treatment plan, medications may target cravings, withdrawal symptoms, or the rewarding effects of drugs. Combining these options with behavioral interventions can support longer-term recovery and improve clinical follow-up.